Concepedia

Nathan VanderVeen

NV

6

Publications

106

Citations

6

H-Index

2013

Active since

Affiliations

University of California, Los Angeles(Current)

Western Michigan University

Baylor College of Medicine

Stryker (United States)

University of Michigan

Nathan VanderVeen is an author at University of California, Los Angeles specializing in medicine, radiation oncology, and oncology.

ORCID

Top concepts

Publications per year

2013–2021

6

Publications

6

Preclinical Characterization of Signal Transducer and Activator of Transcription 3 Small Molecule Inhibitors for Primary and Metastatic Brain Cancer Therapy

Hikmat Assi, Chris Paran, Nathan VanderVeen et al. · Journal of Pharmacology and Experimental Therapeutics · 2014 · 33 citations · Full text

Safety profile, efficacy, and biodistribution of a bicistronic high-capacity adenovirus vector encoding a combined immunostimulation and cytotoxic gene therapy as a prelude to a phase I clinical trial for glioblastoma

Mariana Puntel, Ghulam Muhammad A.K.M., Catherine Farrokhi et al. · Toxicology and Applied Pharmacology · 2013 · 27 citations · Full text

, , +12

Encephalitis with coinfection by Jamestown canyon virus (JCV) and varicella zoster virus (VZV)

Nathan VanderVeen, Nikki Nguyen, Kenny Hoang et al. · IDCases · 2020 · 12 citations · Full text

Combination Therapy With Bortezomib in Renal Medullary Carcinoma: A Case Series

Alixandra Ryan, Karine Tawagi, Nathan VanderVeen et al. · Clinical Genitourinary Cancer · 2021 · 12 citations

, , +7

Effectiveness and Preclinical Safety Profile of Doxycycline to Be Used “Off-Label” to Induce Therapeutic Transgene Expression in a Phase I Clinical Trial for Glioma

Nathan VanderVeen, Christopher Paran, J. Krasinkiewicz et al. · Human Gene Therapy Clinical Development · 2013 · 11 citations · Full text

Rows per page

1–5 of 6